Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP616973.RAWjRd2u2TLd7yD9nUD8epuKJ-IlVWuc7Dr-k_YOJ2iKY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP616973.RAWjRd2u2TLd7yD9nUD8epuKJ-IlVWuc7Dr-k_YOJ2iKY130_assertion type Assertion NP616973.RAWjRd2u2TLd7yD9nUD8epuKJ-IlVWuc7Dr-k_YOJ2iKY130_head.
- NP616973.RAWjRd2u2TLd7yD9nUD8epuKJ-IlVWuc7Dr-k_YOJ2iKY130_assertion description "[Amounts of PGE1, PGE2, and PGF(2alpha), known substrates of 15-PGDH, were markedly increased whereas levels of 13,14-dihydro-15-keto-PGE2, a catabolic product of PGE2, were markedly reduced in NSCLC compared with normal lung.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616973.RAWjRd2u2TLd7yD9nUD8epuKJ-IlVWuc7Dr-k_YOJ2iKY130_provenance.
- NP616973.RAWjRd2u2TLd7yD9nUD8epuKJ-IlVWuc7Dr-k_YOJ2iKY130_assertion evidence source_evidence_literature NP616973.RAWjRd2u2TLd7yD9nUD8epuKJ-IlVWuc7Dr-k_YOJ2iKY130_provenance.
- NP616973.RAWjRd2u2TLd7yD9nUD8epuKJ-IlVWuc7Dr-k_YOJ2iKY130_assertion SIO_000772 19138967 NP616973.RAWjRd2u2TLd7yD9nUD8epuKJ-IlVWuc7Dr-k_YOJ2iKY130_provenance.
- NP616973.RAWjRd2u2TLd7yD9nUD8epuKJ-IlVWuc7Dr-k_YOJ2iKY130_assertion wasDerivedFrom befree-20150227 NP616973.RAWjRd2u2TLd7yD9nUD8epuKJ-IlVWuc7Dr-k_YOJ2iKY130_provenance.
- NP616973.RAWjRd2u2TLd7yD9nUD8epuKJ-IlVWuc7Dr-k_YOJ2iKY130_assertion wasGeneratedBy ECO_0000203 NP616973.RAWjRd2u2TLd7yD9nUD8epuKJ-IlVWuc7Dr-k_YOJ2iKY130_provenance.